[The multifactorial genesis of left ventricle remodeling in patients with essential arterial hypertension]

Kardiologiia
|August 20, 2013
PubMed

Insights

Essential hypertension (EH) involves multifactorial left ventricular remodeling (LVH). Hemodynamic and hormonal factors contribute to both pressure-dependent and volume-dependent LVH in patients with EH.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Vascular Biology

Background:

  • Essential hypertension (EH) is a prevalent cardiovascular condition.
  • Understanding the mechanisms of left ventricular remodeling (LVH) in EH is crucial for patient management.
  • Previous studies suggest complex interactions between hemodynamic and hormonal factors in EH progression.

Purpose of the Study:

  • To investigate the multifactorial genesis of left ventricular remodeling (LVH) in patients with essential hypertension (EH).
  • To explore the associations between hemodynamic, hormonal, and vascular parameters with LVH in different stages of EH.

Main Methods:

  • Echocardiography, radionuclide, and radioimmune methods were used in 122 patients with EH.
  • Carotid-femoral pulse wave velocity (PWV) was measured in 43 patients.
  • Hemodynamic parameters (cardiac index, total peripheral resistance), hormonal levels (renin, aldosterone), and LV geometry were assessed.

Main Results:

  • Stage I EH showed increased cardiac index, which decreased with blood pressure stabilization, accompanied by rising total peripheral resistance.
  • Elevated aldosterone levels were observed across all EH stages; renin levels varied by stage.
  • Concentric LV hypertrophy was the predominant remodeling pattern (62.8%), followed by eccentric LVH (22.1%).
  • Increased PWV was noted in all patients, more pronounced in stage III EH, with significant associations with various hemodynamic, hormonal, and structural parameters.

Conclusions:

  • The development of LVH and LV remodeling in EH is multifactorial.
  • Both hemodynamic and hormonal influences contribute to volume-dependent and pressure-dependent LVH.
  • Pulse wave velocity is a valuable indicator reflecting the severity of EH and its impact on cardiac and vascular structures.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...